IL-37 blocks gouty inflammation by shaping macrophages into a non-inflammatory phagocytic phenotype

Our study revealed that IL-37 could shape macrophages into a 'silent' non-inflammatory phagocytic fashion. IL-37 may become a potentially valuable treatment option for patients of chronic gout, especially for those with tophi.